BioVaxys Technology Corp. (BVAXF)
BVAXF Stock Price Chart
Explore BioVaxys Technology Corp. interactive price chart. Choose custom timeframes to analyze BVAXF price movements and trends.
BVAXF Company Profile
Discover essential business fundamentals and corporate details for BioVaxys Technology Corp. (BVAXF) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
28 Dec 2018
Employees
—
Website
https://www.biovaxys.comCEO
James Christopher Passin
Description
BioVaxys Technology Corp., a clinical biotechnology company, develops antiviral and anticancer vaccine platforms. It develops BVX-0320, a monovalent SARS-CoV-2 vaccine; and BVX-0918A, a haptenized tumor cell vaccine for ovarian cancer, as well as CoviDTH, which screens for an immune system response in patients exposed to SARS-CoV-2. The company is also developing Papilocare for human papilloma virus (HPV)-dependent cervical lesions; BVX-0918C for cervical cancer; BVX-0204 HPV viral vaccine; and BVX-0121, a multivalent SARS-CoV-2 vaccine. BioVaxys Technology Corp. has a bioproduction agreement with WuXi Biologics Limited that produces SARS-CoV-2 s-proteins for BVX-0320 and CoviDTH; research collaboration with The Ohio State University, Wexner School of Medicine for BVX-0320; and agreement with Bioanalytical Systems, Inc. to conduct preclinical toxicology studies for its CoviDTH immunodiagnostic. The company is based in Vancouver, Canada.
BVAXF Financial Timeline
Browse a chronological timeline of BioVaxys Technology Corp. corporate events including earnings releases, dividend announcements, and stock splits.
Earnings released on 31 Mar 2025
EPS came in at -$0.00 .
Earnings released on 19 Mar 2025
EPS came in at -$0.01 .
Earnings released on 31 Jul 2024
EPS came in at -$0.00 .
Earnings released on 5 Jun 2024
EPS came in at $0.00 .
Earnings released on 29 Apr 2024
EPS came in at -$0.00 .
Earnings released on 30 Oct 2023
EPS came in at -$0.02 .
Earnings released on 31 Jul 2023
EPS came in at -$0.00 .
Earnings released on 30 Apr 2023
EPS came in at -$0.01 .
Earnings released on 31 Jan 2023
EPS came in at -$0.01 .
Earnings released on 31 Oct 2022
EPS came in at -$0.06 .
Earnings released on 31 Jul 2022
EPS came in at -$0.01 .
Earnings released on 30 Apr 2022
EPS came in at -$0.01 .
Earnings released on 31 Jan 2022
EPS came in at -$0.01 .
Earnings released on 31 Oct 2021
EPS came in at -$0.02 .
Earnings released on 31 Jul 2021
EPS came in at -$0.01 .
Earnings released on 30 Apr 2021
EPS came in at -$0.01 .
Earnings released on 31 Jan 2021
EPS came in at -$0.02 .
Earnings released on 31 Oct 2020
EPS came in at -$0.02 .
BVAXF Stock Performance
Access detailed BVAXF performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.